Thursday, July 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

US Antimony Secures Leadership and Charts Course for Major Revenue Growth

SiterGedge by SiterGedge
April 1, 2026
in Commodities, Insider Trading, IPOs, Penny Stocks
0
US Antimony Stock
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

United States Antimony Corporation is taking decisive steps to align its executive team with the company’s long-term performance. This strategic move coincides with a pivotal period for the resource company, which recently debuted on the New York Stock Exchange and is positioning itself for a significant expansion in revenue, fueled by a combination of government support and favorable commodity prices.

NYSE Listing and Executive Incentives

The company’s transition to the NYSE, completed on March 11, marks a new chapter in its corporate development. Shortly following this milestone, the board of directors approved a substantial equity award for CEO Gary C. Evans. The grant consists of 304,524 Restricted Stock Units (RSUs), which are scheduled to vest in increments over the coming two years. This incentive plan is designed to retain leadership during a phase of substantial financial strengthening.

Should investors sell immediately? Or is it worth buying US Antimony?

Operational results provide a solid foundation for the board’s confidence. For the 2025 fiscal year, United States Antimony reported a remarkable 163 percent surge in revenue, which exceeded $39 million. This dramatic increase was primarily driven by a sharp rise in global antimony prices, which on average more than tripled. Consequently, the company’s gross profit also saw impressive growth, advancing by 185 percent year-over-year.

Defense Contracts and Expansion Funding

A key growth driver for the current period is a contract secured with the U.S. Department of Defense under the Defense Production Act. The funding provided through this agreement is earmarked for modernizing the company’s refining operations. This strategic government investment, coupled with sustained high prices for its core commodity, is propelling the firm’s expansion plans forward.

Ad

US Antimony Stock: Buy or Sell?! New US Antimony Analysis from July 2 delivers the answer:

The latest US Antimony figures speak for themselves: Urgent action needed for US Antimony investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 2.

US Antimony: Buy or sell? Read more here...

Tags: US Antimony
SiterGedge

SiterGedge

Related Posts

Rock Tech Lithium Stock
Commodities

Rock Tech Lithium Secures Mandate for Reverse Share Consolidation as Dual-Continent Strategy Intensifies

July 1, 2026
Almonty Stock
Commodities

A Pentagon Deadline Ignites the Race for Tungsten Independence

July 1, 2026
SpaceX Stock
IPOs

SpaceX’s Fractured Launch: A $25 Billion Bond, a $60 Billion AI Bet, and a Record-Breaking Index Entry

June 30, 2026
Next Post
Halliburton Stock

Halliburton's Automated Drilling Breakthrough in Guyana Draws Market Focus

SolarEdge Stock

SolarEdge Shares Under Pressure Amid Persistent Losses

Achieve Life Sciences Stock

The June 2026 Deadline: Achieve Life Sciences Awaits Key FDA Verdict

Recommended

Moelis Stock

Moelis & Company Posts Stellar Quarterly Results and Announces Leadership Transition

10 months ago
Biolife Stock

Leadership Exodus and Earnings Shortfall Cast Shadow on Biolife

9 months ago
The Trade Desk Stock

The Trade Desk’s $750 Million War Chest and a CEO’s $150 Million Conviction Play

2 months ago

Nitrousinks Groundbreaking Patent Application Revolutionizing Agricultural Sustainability

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

STMicroelectronics: Analyst Upgrade Can’t Stem 7% Selloff as Rally Shows Signs of Exhaustion

Rock Tech Lithium Secures Mandate for Reverse Share Consolidation as Dual-Continent Strategy Intensifies

XPeng’s Record Second-Quarter Deliveries Overshadow a Daunting Gap to Its Annual Goal

Outlook Therapeutics: A 950% Rally Meets a Reality Check on Dilution

AST SpaceMobile’s Infrastructure Pivot: From Consumer Dream to Carrier Gatekeeper Dependency

MiCA Deadline Clears the Field as Institutions Circle DeFi Technologies’ Distressed Stock

Trending

Nel ASA Stock
Analysis

Nel ASA’s 200-Day Line Holds the Spotlight as Samsung Stake and Leadership Void Send Mixed Signals

by Jackson Burston
July 2, 2026
0

The clock is ticking for Nel ASA. The hydrogen-equipment maker’s stock has slid 36 percent in the...

Mutares Stock

Mutares Nears Pivotal Summer AGM With BaFin All-Clear and Efacec Exit in the Crosshairs

July 1, 2026
Fuelcell Energy Stock

FuelCell Energy Rides the AI Current — But the Backlash Was Just as Sharp

July 1, 2026
STMicroelectronics Stock

STMicroelectronics: Analyst Upgrade Can’t Stem 7% Selloff as Rally Shows Signs of Exhaustion

July 1, 2026
Rock Tech Lithium Stock

Rock Tech Lithium Secures Mandate for Reverse Share Consolidation as Dual-Continent Strategy Intensifies

July 1, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s 200-Day Line Holds the Spotlight as Samsung Stake and Leadership Void Send Mixed Signals
  • Mutares Nears Pivotal Summer AGM With BaFin All-Clear and Efacec Exit in the Crosshairs
  • FuelCell Energy Rides the AI Current — But the Backlash Was Just as Sharp

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com